Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $105.5M | |||
| Open | High | Low | Value | Volume |
| 92.5¢ | 97.5¢ | 92.0¢ | $80.23K | 85.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1076 | 93.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 3000 | 1 |
View Market Depth
| Last trade - 15.58pm 25/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |